DOMESTIC SPECTRUM OF ANTIVIRAL DRUG — UMIFENOVIR AS ETIOTROPIC THERAPY OF INFLUENZA

Abstract

In this article are presented the results of comparative observation of the effectiveness of the inclusion in the complex therapy of 203 hospitalized children aged 2 years and older with influenza А(Н1N1)pdm09 domestic antiviral drug — Umifenovir (Arbidol) that occurred during the epidemic seasons 2009—2013 and 2015—2016 in terms of observational clinical studies. It is shown that this drug, possessing a wide spectrum of antiviral activity, including against Oseltamivir — and Zanamivir-resistant influenza virus strains, antioxidant activity and low toxicity (Code ATX Ј05АХ13), can be successfully used in the treatment of infants with influenza А(Н1N1)pdm09.

Keywords

• influenza а(н1n1)pdm09
• children
• the antiviral drug — umifenovir
• treatment